Medifast Share Price Loses Weight, But Is There Still Value To Be Had? (NYSE:MED)

[ad_1]

Feet of an Asian woman on a weight scale

mapo/iStock via Getty Images

If you were looking at medium-to-small companies trading around a 52-week low but with some favorable numbers behind them, it won’t take long and you’ll eventually come across Medifast (NYSE:MED), the weight loss and

Cash & Equivalents $113 million
Total Current Assets $224 million
Total Assets $320 million
Total Current Liabilities $110 million
Total Liabilities $127 million
Shareholder Equity $193 million
Debt/Equity 0.66
Price/Book 2.93

2021 2022 2023 (9 mo.)
Revenue $1.52 billion $1.60 billion $881 million
Gross Profit $1.13 billion $1.14 billion $634 million
Operating Income $216 million $185 million $118 million
Net Income $164 million $143 million $93 million

2021 2022 2023
Operating Free Cash $94 million $194 million $137 million
Investing Free Cash ($29 million) ($11 million) ($50 million)
Financing Free Cash ($125 million) ($199 million) ($62 million)

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *